Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children

NCT00317473 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

135

Enrollment

FED

Sponsor class

Conditions

Plasmodium Falciparum Malaria

Interventions

BIOLOGICAL: FMP1/AS02A Malaria vaccine
BIOLOGICAL: Imovax Rabies vaccine

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]